Novartis Pharma and expectation in 2014

Novartis Pharmaceuticals is a multinational group of companies, which is in the medicine industry. The company specializes in the research and development, manufacturing and selling of products in pharmaceutical industry.
Novartis Pharma is traded on New York Stock Exchange with the symbol NVS and Novartis current stock price is $ 81.5. Novartis Pharma has been in talks with Merck to buy their consumer health care business unit in the coming year. The talks have not been publicized by either of the companies. The Consumer health unit of Merck is worth 10 to 12 Billion and if Novartis Pharma acquires this big unit then it will increase its market share in the consumer health products since Merck’s Consumer Health Business unit have a lot of successful products which can give Novartis company huge growth prospects in the coming Year. Although in the Pharma business many important players are cutting back on their research and development budget Novartis Chief executive announce recently that Novartis Pharma will maintain its current Research and development budget and assured that there will be no cutbacks in the research department of the company and the employees need not worry about the industry cutbacks.